Similarly, our work may help in the design of truncated dystrophin molecules to be expressed, either by gene replacement or by exon skipping, in Duchenne muscular dystrophy patients who lack dystrophin [63], [74]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.